# Arhaus, Inc.: financial statements, quarterly

ARHS · Nasdaq · CIK 1875444 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arhs.md) · [Financials](/companies/arhs/financials.md) · [Filings](/companies/arhs/filings.md) · [Insiders](/companies/arhs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/arhs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [326](/filings/0001875444-24-000136.md) | [344 d](/filings/0001875444-26-000010.md) | [295](/filings/0001875444-25-000087.md) | [310](/filings/0001875444-25-000135.md) | [319](/filings/0001875444-25-000146.md) | [347 d](/filings/0001875444-26-000010.md) | [311](/filings/0001875444-26-000016.md) | [358](/filings/0001875444-26-000030.md) | [345](/filings/0001875444-25-000146.md) | [365 d](/filings/0001875444-26-000010.md) | [314](/filings/0001875444-26-000016.md) | [385](/filings/0001875444-26-000030.md) |
| Cost of revenue | $m | [195](/filings/0001875444-24-000136.md) | [203 d](/filings/0001875444-26-000010.md) | [180](/filings/0001875444-25-000087.md) | [185](/filings/0001875444-25-000135.md) | [196](/filings/0001875444-25-000146.md) | [208 d](/filings/0001875444-26-000010.md) | [196](/filings/0001875444-26-000016.md) | [210](/filings/0001875444-26-000030.md) | [211](/filings/0001875444-25-000146.md) | [226 d](/filings/0001875444-26-000010.md) | [200](/filings/0001875444-26-000016.md) | [213](/filings/0001875444-26-000030.md) |
| Gross profit | $m | [131](/filings/0001875444-24-000136.md) | [141 d](/filings/0001875444-26-000010.md) | [115](/filings/0001875444-25-000087.md) | [124](/filings/0001875444-25-000135.md) | [123](/filings/0001875444-25-000146.md) | [139 d](/filings/0001875444-26-000010.md) | [116](/filings/0001875444-26-000016.md) | [148](/filings/0001875444-26-000030.md) | [133](/filings/0001875444-25-000146.md) | [139 d](/filings/0001875444-26-000010.md) | [114](/filings/0001875444-26-000016.md) | [172](/filings/0001875444-26-000030.md) |
| Selling, general and administrative | $m | [107](/filings/0001875444-24-000136.md) | [100 d](/filings/0001875444-26-000010.md) | [96.7](/filings/0001875444-25-000087.md) | [95.0](/filings/0001875444-25-000135.md) | [112](/filings/0001875444-25-000146.md) | [111 d](/filings/0001875444-26-000010.md) | [110](/filings/0001875444-26-000016.md) | [101](/filings/0001875444-26-000030.md) | [117](/filings/0001875444-25-000146.md) | [119 d](/filings/0001875444-26-000010.md) | [112](/filings/0001875444-26-000016.md) | [118](/filings/0001875444-26-000030.md) |
| Operating income | $m | [23.9](/filings/0001875444-24-000136.md) | [41.0 d](/filings/0001875444-26-000010.md) | [18.4](/filings/0001875444-25-000087.md) | [29.4](/filings/0001875444-25-000135.md) | [10.7](/filings/0001875444-25-000146.md) | [28.6 d](/filings/0001875444-26-000010.md) | [5.4](/filings/0001875444-26-000016.md) | [46.8](/filings/0001875444-26-000030.md) | [16.4](/filings/0001875444-25-000146.md) | [20.3 d](/filings/0001875444-26-000010.md) | [2.1](/filings/0001875444-26-000016.md) | [54.3](/filings/0001875444-26-000030.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [5.3](/filings/0001875444-24-000136.md) | [11.7 d](/filings/0001875444-26-000010.md) | [4.8](/filings/0001875444-25-000087.md) | [7.8](/filings/0001875444-25-000135.md) | [1.5](/filings/0001875444-25-000146.md) | [8.2 d](/filings/0001875444-26-000010.md) | [1.2](/filings/0001875444-26-000016.md) | [12.6](/filings/0001875444-26-000030.md) | [5.2](/filings/0001875444-25-000146.md) | [5.8 d](/filings/0001875444-26-000010.md) | [1.2](/filings/0001875444-26-000016.md) | [15.7](/filings/0001875444-26-000030.md) |
| Net income | $m | [19.7](/filings/0001875444-24-000136.md) | [31.2 d](/filings/0001875444-26-000010.md) | [15.1](/filings/0001875444-25-000087.md) | [22.2](/filings/0001875444-25-000135.md) | [9.9](/filings/0001875444-25-000146.md) | [21.3 d](/filings/0001875444-26-000010.md) | [4.9](/filings/0001875444-26-000016.md) | [35.1](/filings/0001875444-26-000030.md) | [12.2](/filings/0001875444-25-000146.md) | [15.1 d](/filings/0001875444-26-000010.md) | [2.2](/filings/0001875444-26-000016.md) | [39.6](/filings/0001875444-26-000030.md) |
| Diluted EPS | $ per share | [0.14](/filings/0001875444-24-000136.md) | not reported | [0.11](/filings/0001875444-25-000087.md) | [0.16](/filings/0001875444-25-000135.md) | [0.07](/filings/0001875444-25-000146.md) | not reported | [0.03](/filings/0001875444-26-000016.md) | [0.25](/filings/0001875444-26-000030.md) | [0.09](/filings/0001875444-25-000146.md) | not reported | [0.02](/filings/0001875444-26-000016.md) | [0.28](/filings/0001875444-26-000030.md) |
| Basic EPS | $ per share | [0.14](/filings/0001875444-24-000136.md) | not reported | [0.11](/filings/0001875444-25-000087.md) | [0.16](/filings/0001875444-25-000135.md) | [0.07](/filings/0001875444-25-000146.md) | not reported | [0.03](/filings/0001875444-26-000016.md) | [0.25](/filings/0001875444-26-000030.md) | [0.09](/filings/0001875444-25-000146.md) | not reported | [0.02](/filings/0001875444-26-000016.md) | [0.28](/filings/0001875444-26-000030.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [237](/filings/0001875444-24-000069.md) | [223](/filings/0001875444-25-000021.md) | [233](/filings/0001875444-24-000071.md) | [174](/filings/0001875444-24-000128.md) | [178](/filings/0001875444-24-000136.md) | [198](/filings/0001875444-26-000010.md) | [214](/filings/0001875444-25-000087.md) | [235](/filings/0001875444-25-000135.md) | [262](/filings/0001875444-25-000146.md) | [253](/filings/0001875444-26-000030.md) | [177](/filings/0001875444-26-000016.md) | [226](/filings/0001875444-26-000030.md) |
| Current assets | $m | [535](/filings/0001875444-24-000136.md) | [509](/filings/0001875444-25-000021.md) | [540](/filings/0001875444-24-000071.md) | [491](/filings/0001875444-24-000128.md) | [509](/filings/0001875444-24-000136.md) | [531](/filings/0001875444-26-000010.md) | [553](/filings/0001875444-25-000087.md) | [578](/filings/0001875444-25-000135.md) | [626](/filings/0001875444-25-000146.md) | [621](/filings/0001875444-26-000030.md) | [582](/filings/0001875444-26-000016.md) | [643](/filings/0001875444-26-000030.md) |
| Total assets | $m | [1,114](/filings/0001875444-24-000136.md) | [1,105](/filings/0001875444-25-000021.md) | [1,176](/filings/0001875444-24-000071.md) | [1,177](/filings/0001875444-24-000128.md) | [1,209](/filings/0001875444-24-000136.md) | [1,206](/filings/0001875444-26-000010.md) | [1,265](/filings/0001875444-25-000087.md) | [1,318](/filings/0001875444-25-000135.md) | [1,379](/filings/0001875444-25-000146.md) | [1,395](/filings/0001875444-26-000030.md) | [1,378](/filings/0001875444-26-000016.md) | [1,450](/filings/0001875444-26-000030.md) |
| Current liabilities | $m | [389](/filings/0001875444-24-000136.md) | [342](/filings/0001875444-25-000021.md) | [447](/filings/0001875444-24-000071.md) | [392](/filings/0001875444-24-000128.md) | [416](/filings/0001875444-24-000136.md) | [402](/filings/0001875444-26-000010.md) | [437](/filings/0001875444-25-000087.md) | [435](/filings/0001875444-25-000135.md) | [466](/filings/0001875444-25-000146.md) | [453](/filings/0001875444-26-000030.md) | [466](/filings/0001875444-26-000016.md) | [484](/filings/0001875444-26-000030.md) |
| Total liabilities | $m | [805](/filings/0001875444-24-000136.md) | [765](/filings/0001875444-25-000021.md) | [891](/filings/0001875444-24-000071.md) | [868](/filings/0001875444-24-000128.md) | [889](/filings/0001875444-24-000136.md) | [863](/filings/0001875444-26-000010.md) | [916](/filings/0001875444-25-000087.md) | [933](/filings/0001875444-25-000135.md) | [978](/filings/0001875444-25-000146.md) | [977](/filings/0001875444-26-000030.md) | [1,005](/filings/0001875444-26-000016.md) | [1,036](/filings/0001875444-26-000030.md) |
| Shareholders' equity | $m | [308](/filings/0001875444-24-000069.md) | [340](/filings/0001875444-26-000010.md) | [286](/filings/0001875444-25-000135.md) | [309](/filings/0001875444-25-000146.md) | [321](/filings/0001875444-25-000146.md) | [344](/filings/0001875444-26-000030.md) | [349](/filings/0001875444-26-000030.md) | [386](/filings/0001875444-26-000030.md) | [400](/filings/0001875444-25-000146.md) | [418](/filings/0001875444-26-000030.md) | [373](/filings/0001875444-26-000030.md) | [415](/filings/0001875444-26-000030.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [83.7 d](/filings/0001875444-24-000136.md) | [20.8 d](/filings/0001875444-26-000010.md) | [36.8](/filings/0001875444-25-000087.md) | [47.5 d](/filings/0001875444-25-000135.md) | [31.1 d](/filings/0001875444-25-000146.md) | [31.7 d](/filings/0001875444-26-000010.md) | [46.5](/filings/0001875444-26-000016.md) | [34.9 d](/filings/0001875444-26-000030.md) | [46.1 d](/filings/0001875444-25-000146.md) | [9.3 d](/filings/0001875444-26-000010.md) | [(9.7)](/filings/0001875444-26-000016.md) | [69.5 d](/filings/0001875444-26-000030.md) |
| Capital expenditure | $m | [23.6 d](/filings/0001875444-24-000136.md) | [34.6 d](/filings/0001875444-26-000010.md) | [25.9](/filings/0001875444-25-000087.md) | [36.2 d](/filings/0001875444-25-000135.md) | [26.5 d](/filings/0001875444-25-000146.md) | [18.7 d](/filings/0001875444-26-000010.md) | [27.6](/filings/0001875444-26-000016.md) | [14.0 d](/filings/0001875444-26-000030.md) | [18.1 d](/filings/0001875444-25-000146.md) | [18.1 d](/filings/0001875444-26-000010.md) | [16.9](/filings/0001875444-26-000016.md) | [21.2 d](/filings/0001875444-26-000030.md) |
| Dividends paid | $m | [0.0 d](/filings/0001875444-24-000136.md) | [0.0 d](/filings/0001875444-26-000010.md) | [0.0](/filings/0001875444-25-000087.md) | [70.1 d](/filings/0001875444-25-000135.md) | [0.1 d](/filings/0001875444-25-000146.md) | [0.1 d](/filings/0001875444-26-000010.md) | [0.2](/filings/0001875444-26-000016.md) | [0.0 d](/filings/0001875444-26-000030.md) | [0.1 d](/filings/0001875444-25-000146.md) | [0.0 d](/filings/0001875444-26-000010.md) | [49.5](/filings/0001875444-26-000016.md) | [0.1 d](/filings/0001875444-26-000030.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [140](/filings/0001875444-24-000069.md) | [140](/filings/0001875444-24-000071.md) | [140](/filings/0001875444-24-000128.md) | [140](/filings/0001875444-24-000136.md) | [141](/filings/0001875444-25-000087.md) | [141](/filings/0001875444-25-000135.md) | [141](/filings/0001875444-25-000146.md) | [141](/filings/0001875444-26-000016.md) | [141](/filings/0001875444-26-000030.md) | [142](/filings/0001875444-25-000146.md) | [142](/filings/0001875444-26-000016.md) | [142](/filings/0001875444-26-000030.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 136,946,392 at 2021-12-01, from the cover of the [10-Q/A filed 2021-12-09](/filings/0001875444-21-000022.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.